Cronos Group, Inc. (CRON)
3.225
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 13:35
Cronos Group Price : 3.225 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 3.22 | 3.235 | 3.15 | 3.22 | 974240.0 |
| Oct 07, 2026 | 3.26 | 3.297 | 3.24 | 3.24 | 456035.0 |
| Oct 06, 2026 | 3.26 | 3.30 | 3.24 | 3.285 | 677801.0 |
| Oct 05, 2026 | 3.23 | 3.319 | 3.23 | 3.25 | 1.217M |
| Oct 02, 2026 | 3.25 | 3.28 | 3.19 | 3.225 | 1.237M |
| Oct 01, 2026 | 3.27 | 3.30 | 3.21 | 3.21 | 1.322M |
| Sep 30, 2026 | 3.37 | 3.38 | 3.25 | 3.30 | 1.821M |
| Sep 29, 2026 | 3.42 | 3.43 | 3.365 | 3.38 | 761987.0 |
| Sep 28, 2026 | 3.31 | 3.455 | 3.29 | 3.41 | 1.134M |
| Sep 25, 2026 | 3.32 | 3.35 | 3.25 | 3.34 | 876523.0 |
| Sep 24, 2026 | 3.40 | 3.418 | 3.315 | 3.32 | 721206.0 |
| Sep 23, 2026 | 3.455 | 3.455 | 3.385 | 3.40 | 512824.0 |
| Sep 22, 2026 | 3.34 | 3.46 | 3.335 | 3.43 | 768479.0 |
| Sep 21, 2026 | 3.35 | 3.39 | 3.31 | 3.33 | 472128.0 |
| Sep 18, 2026 | 3.38 | 3.40 | 3.34 | 3.35 | 1.071M |
| Sep 17, 2026 | 3.33 | 3.41 | 3.31 | 3.37 | 748087.0 |
| Sep 16, 2026 | 3.22 | 3.37 | 3.22 | 3.29 | 1.052M |
| Sep 15, 2026 | 3.22 | 3.22 | 3.16 | 3.20 | 591461.0 |
| Sep 14, 2026 | 3.10 | 3.24 | 3.09 | 3.235 | 913268.0 |
| Sep 11, 2026 | 3.18 | 3.185 | 3.11 | 3.14 | 710828.0 |
| Sep 10, 2026 | 3.12 | 3.19 | 3.12 | 3.16 | 584730.0 |
| Sep 09, 2026 | 3.18 | 3.195 | 3.13 | 3.155 | 605773.0 |
| Sep 08, 2026 | 3.24 | 3.255 | 3.17 | 3.185 | 929831.0 |
| Sep 04, 2026 | 3.22 | 3.27 | 3.215 | 3.26 | 493811.0 |
| Sep 03, 2026 | 3.28 | 3.29 | 3.21 | 3.26 | 1.179M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Lexaria Bioscience Corp. | 3.63 |
| Target Group, Inc. (Canada) | 0.0005 |
| InMed Pharmaceuticals, Inc. | 1.37 |
| XORTX Therapeutics, Inc. | 1.46 |
| NervGen Pharma Corp. | 1.73 |
Price Related Metrics
| PE Ratio | 17.51 |
| PS Ratio | 6.863 |
| PEG Ratio | 0.0610 |
| Price to Book Value | 1.119 |
| Price to Free Cash Flow | 24.77 |
| Earnings Yield | 5.71% |
| Market Cap | 1.196B |
| PEGY Ratio | 0.0610 |
| Normalized PE Ratio | 16.29 |